Nerudia announced the appointment of Dr Paul Marshall as regulatory principal, a position in which he will advise clients on regulatory aspects of nicotine delivery.

Marshall is an experienced regulatory scientist whose work experience includes the UK Medicines and Health products Regulatory Agency (MHRA), where he was a senior pharmaceutical assessor for nicotine products, Nerudia said. In his new position, he will report to Rob Burton, head of consultancy and compliance at the e-cigarette company.